{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T04:02:43Z","timestamp":1746417763694,"version":"3.40.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"16","license":[{"start":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T00:00:00Z","timestamp":1619136000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project of Ningbo Science and Technology Bureau","award":["2019C50078"],"award-info":[{"award-number":["2019C50078"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Currently, there are no meta-analyses evaluating the efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction. Our protocol is conceived to evaluate the efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We will follow the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) reporting guidelines and the recommendations of the Cochrane Collaboration to conduct this meta-analysis. The systematic review protocol has been registered in Open Science Framework registries. The following databases including PubMed, Cochrane Library, Web of Science, and EMBASE will be searched using the key phrases \u201cloop diuretics,\u201d \u201cfurosemide,\u201d \u201cheart failure,\u201d and \u201crenal dysfunction\u201d for all randomized clinical trials (RCTs) published up to May 2021. Revman 5.3 (Nordic Cochrane Centre, Denmark) will be used to complete the meta-analysis and generate forest plots. We will choose between a fixed effects and random effects model based upon the heterogeneity of included studies. Significance will be set at <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.05.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Our protocol is conceived to test the hypothesis that continuous furosemide could lead to better outcomes in patients presenting with heart failure concomitant renal dysfunction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Registration number:<\/jats:title>\n            <jats:p>10.17605\/OSF.IO\/CQZRS.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025669","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T13:35:10Z","timestamp":1619012110000},"page":"e25669","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of intermittent vs continuous furosemide for heart failure concomitant renal dysfunction"],"prefix":"10.1097","volume":"100","author":[{"given":"Siqi","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,23]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1253\/circj.CJ-09-0062","article-title":"Chronic kidney disease as an independent risk for long-term adverse outcomes in patients hospitalized with heart failure in Japan. Report from the Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)","volume":"73","author":"Hamaguchi","year":"2009","journal-title":"Circ J"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1536\/ihj.16-625","article-title":"Impact of continuous administration of tolvaptan on preventing medium-term worsening renal function and long-term adverse events in heart failure patients with chronic kidney disease","volume":"59","author":"Nakano","year":"2018","journal-title":"Int Heart J"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cardfail.2006.02.007","article-title":"Secular trends in renal dysfunction and outcomes in hospitalized heart failure patients","volume":"12","author":"Owan","year":"2006","journal-title":"J Card Fail"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehi859","article-title":"Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH)","volume":"27","author":"Cowie","year":"2006","journal-title":"Eur Heart J"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurheartj\/ehi696","article-title":"Incidence of renal dysfunction over 6\u200amonths in patients with chronic heart failure due to left ventricular systolic dysfunction: contributing factors and relationship to prognosis","volume":"27","author":"de Silva","year":"2006","journal-title":"Eur Heart J"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2003.08.012","article-title":"Relationship between heart failure treatment and development of worsening renal function among hospitalized patients","volume":"147","author":"Butler","year":"2004","journal-title":"Am Heart J"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ahj.2011.12.003","article-title":"Incidence, clinical predictors, and prognostic impact of worsening renal function in elderly patients with chronic heart failure on intensive medical therapy","volume":"163","author":"Maeder","year":"2012","journal-title":"Am Heart J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2005.12.072","article-title":"Relation of loop diuretic dose to mortality in advanced heart failure","volume":"97","author":"Eshaghian","year":"2006","journal-title":"Am J Cardiol"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1536\/ihj.16-227","article-title":"Prognostic impacts of hyponatremia, renal dysfunction, and high-dose diuretics during a 10-year study period in 4,087 Japanese heart failure patients","volume":"57","author":"Imamura","year":"2016","journal-title":"Int Heart J"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.cardfail.2009.11.005","article-title":"Continuous versus intermittent infusion of furosemide in acute decompensated heart failure","volume":"16","author":"Thomson","year":"2010","journal-title":"J Card Fail"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00392-019-01521-y","article-title":"Diuretic treatment in high-risk acute decompensation of advanced chronic heart failure-bolus intermittent vs. continuous infusion of furosemide: a randomized controlled trial","volume":"109","author":"Frea","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"R12-20250504","doi-asserted-by":"crossref","DOI":"10.1002\/ehf2.13286","article-title":"Continuous versus intermittent use of furosemide in patients with heart failure and moderate chronic renal dysfunction","author":"Zheng","year":"2021","journal-title":"ESC Heart Fail"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025669","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:11:33Z","timestamp":1746339093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025669"}},"subtitle":["A protocol for systematic review and meta-analysis"],"short-title":[],"issued":{"date-parts":[[2021,4,23]]},"references-count":12,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025669","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2021,4,23]]},"assertion":[{"value":"2021-04-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}